该激光器采用可伐-玻璃封接和自由电位板电晕预电离技术。
Using the free-potential electrode corona preionization technique, a compact, rugged, stable and reliable device has been achieved.
在镀层有缺陷时，镀金、镀镍层均促进可伐合金的应力腐蚀开裂。
When defect exists in the plating the gold-plating, nickel-plating both promote the stress-corrosion fracture of the Kovar alloy.
可伐合金废料首先用盐酸通氯溶解，使钴、镍、铁进入溶液而金不溶。
The kovar scrap is first dissolved with hydrochloric acid and chlorine.
含锆低钴可伐4 J 461是一种性能良好而廉价的新型封接合金。
The low-cobalt kovar alloy 4j461 with a little Zr is a new type metal-ceramic sealing alloy with good performance and low cost.
阿托伐醌氯胍药可预防疟疾。
第一年，进行贝伐单抗注射的32%的患者的可认字母增加了15个，而标准治疗方案组的患者增加了3%。
At one year, 32% of patients in the bevacizumab group gained 15 or more letters from baseline visual acuity compared with 3% in the standard care group.
阿托伐他汀联合低脂肪饮食可降低血液中的LDL胆固醇和甘油三酯。
Atorvastatin is used along with a low-fat diet to lower the LDL cholesterol and triglycerides in the blood.
结论：行血管手术的患者，围术期氟伐他汀治疗可改善术后心脏结局。
Conclusions: in patients undergoing vascular surgery, perioperative fluvastatin therapy was associated with an improvement in postoperative cardiac outcome.
通过伊伐布雷定降低载脂蛋白e缺陷小鼠心率，可降低氧化应激水平、改善血管内皮功能、预防动脉粥样硬化。
Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E-Deficient Mice.
采用化学治疗药物(贝伐单抗，是中和血管内皮生长因子的人源化抗体)治疗可导致蛋白尿和肾功能损害。
Treatment with the chemotherapeutic agent bevacizumab, a humanized mab that neutralizes vascular endothelial growth factor, can lead to proteinuria and renal damage.
结论：作者的结论是，行血管手术的患者中，围术期氟伐他汀治疗可改善术后心脏结局。
Conclusions: the authors concluded that among patients undergoing vascular surgery, perioperative fluvastatin therapy was associated with an improvement in postoperative cardiac outcome.
例外的是，这些药物也有临床明显的药物副作用——贝伐单抗可致高血压，吉非替尼和厄洛替尼可有皮肤毒性。
Fortuitously, these drugs also have clinically obvious pharmacodynamic end points-hypertension for bevacizumab and skin toxicity for erlotinib and gefitinib.
结论国产匹伐他汀可明显降低TC、LDLC，且剂量低，调脂疗效确切、安全性好，可用于治疗原发性高脂血症患者。
Conclusion Pitavastatin could decrease the levels of TC, LDLC, with definite efficiency and safety, and could be used in the treatment of hyperlipidemia.
结论国产匹伐他汀可明显降低TC、LDLC，且剂量低，调脂疗效确切、安全性好，可用于治疗原发性高脂血症患者。
Conclusion Pitavastatin could decrease the levels of TC, LDLC, with definite efficiency and safety, and could be used in the treatment of hyperlipidemia.
应用推荐